CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Unum Therapeutics Inc Company Snapshot
Unum Therapeutics Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Unum Therapeutics Inc with three other companies in this sector in UNITED STATES : Histogen Inc (2019 sales of $21.72 million of which 100% was single segment), Molecular Templates Inc ($22.27 million of which 100% was Pharmaceuticals), and Adamis Pharmaceuticals Corp ($22.11 million of which 100% was Development and sale of Pharmaceutical a).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Unum Therapeutics Inc
  Stock Performance Chart for Unum Therapeutics Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (9/25/2020): 2.28
(Figures in U.S. Dollars)
1 Week -22.4%   13 Weeks -20.6%  
4 Weeks 424.4%   52 Weeks 43.4%  
 
Unum Therapeutics Inc Key Data:
  Ticker: UMRX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 22,499,000
(Year Ending Jan 2020).
Employees: 72
  Currency: U.S. Dollars Market Cap: 71,049,225
  Fiscal Yr Ends: December Shares Outstanding: 31,161,941
  Share Type: Common Closely Held Shares: 11,109,862
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.